BF Biosciences Limited (PSX:BFBIO)
Pakistan · Delayed Price · Currency is PKR 138.18
-0.02 (-0.01%)
At close: Aug 20, 2026
BF Biosciences Financials Overview
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 8,859 | 5,837 | 3,659 | 1,810 | 1,521 | 1,755 |
Revenue Growth | 78.72% | 59.55% | 102.19% | 18.99% | -13.34% | 179.30% |
Gross Profit Gross Profit Growth | 3,737 | 2,285 | 1,531 | 447.24 | 457.77 | 796.47 |
Operating Income Operating Income Growth | 977.88 | 734.56 | 711.15 | 269.29 | 242.23 | 601.18 |
Net Income Net Income Growth | 591.76 | 447.15 | 385.41 | 149.05 | 306.98 | 607.99 |
Earnings Per Share EPS Growth | 6.70 | 5.52 | 6.09 | 2.35 | 4.85 | 9.60 |
EPS Growth | 27.76% | -9.21% | 158.57% | -51.45% | -49.51% | 1190.62% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Pakistan Pakistan Growth | 9,028 | 5,724 | 3,606 | 1,769 | 1,049 |
Nepal Nepal Growth | - | 39.08 | 33.89 | 30.49 | - |
Afghanistan Afghanistan Growth | - | 32.51 | - | - | - |
Sri Lanka Sri Lanka Growth | - | - | 8.44 | 5.72 | - |
Mauritania Mauritania Growth | - | 17.8 | - | - | - |
Others Others Growth | - | 7.61 | 9.9 | 4.72 | - |
Switzerland Switzerland Growth | - | 16.82 | - | - | - |
Total Total Growth | 8,859 | 5,837 | 3,659 | 1,810 | 1,520 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 895.05 | 1,511 | 317.78 | 402.83 | 1,710 | 1,271 |
Total Debt Total Debt Growth | 1,724 | 1,725 | 2,212 | 2,603 | 1,744 | 889.38 |
Net Cash (Debt) Net Cash Growth | -828.77 | -213.54 | -1,894 | -2,200 | -34.26 | 381.13 |
Net Cash Growth | - | - | - | - | - | -27.32% |
Net Cash Per Share Net Cash Per Share Growth | -9.38 | -2.64 | -29.91 | -34.74 | -0.54 | 6.02 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 297.3 | 299.79 | 664.7 | -196.07 | 178 | 570 |
Capital Expenditures CapEx Growth | -513.91 | -329.49 | -143.13 | -1,968 | -1,130 | -941 |
Free Cash Flow Free Cash Flow Growth | -216.61 | -29.71 | 521.57 | -2,164 | -952 | -371 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 42.19% | 39.13% | 41.84% | 24.72% | 30.10% | 45.39% |
Operating Margin | 11.04% | 12.58% | 19.44% | 14.88% | 15.93% | 34.26% |
Pretax Margin | 11.43% | 12.40% | 15.90% | 11.17% | 22.93% | 36.79% |
Profit Margin | 6.68% | 7.66% | 10.53% | 8.24% | 20.19% | 34.65% |
FCF Margin | -2.44% | -0.51% | 14.26% | -119.61% | -62.60% | -21.14% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 20, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 20.62 | 33.33 | - | - | - | - |
Forward PE | - | 22.57 | - | - | - | - |
PS Ratio | 1.38 | 2.55 | - | - | - | - |